ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. C100 医学部/医学系研究科
  2. C100a 雑誌掲載論文
  3. 学術雑誌

Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathy

http://hdl.handle.net/2237/27073
http://hdl.handle.net/2237/27073
86febf11-c023-4cf8-9025-d47e602c2678
名前 / ファイル ライセンス アクション
CCA-D-17-00162R2_1.pdf CCA-D-17-00162R2_1.pdf ファイル公開日:2018/08/01 (372.7 kB)
アイテムタイプ 学術雑誌論文 / Journal Article(1)
公開日 2017-11-07
タイトル
タイトル Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathy
言語 en
著者 Mariko, Ogawa-Momohara

× Mariko, Ogawa-Momohara

WEKO 73920

en Mariko, Ogawa-Momohara

Search repository
Yoshinao, Muro

× Yoshinao, Muro

WEKO 73921

en Yoshinao, Muro

Search repository
Minoru, Satoh

× Minoru, Satoh

WEKO 73922

en Minoru, Satoh

Search repository
Masashi, Akiyama

× Masashi, Akiyama

WEKO 73923

en Masashi, Akiyama

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利
権利情報 © 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
言語 en
抄録
内容記述タイプ Abstract
内容記述 Background: Anti-Su antibodies are found in 5–20% of cases of various systemic autoimmune rheumatic diseases and in 5–10% of dermatomyositis (DM)/polymyositis (PM) patients. In 2006, the 100 kDa Su antigen was identified as argonaute2 (Ago2), and it was found to play a major role in RNA interference. However, immunoprecipitation (IP) remains the main method for detecting anti-Su and the clinical significance of the antibodies is uncertain. Methods: Sera from patients with DM/PM (n = 224) were screened by an ELISA that uses recombinant biotinylated Ago2 protein. Some serum samples were tested by IP and by indirect immunofluorescence (IIF) analysis. Results: Seventeen (7.5%, 17/224) sera from DM/PM were positive in ELISA. Of the 33 IP-tested sera (17 ELISApositive and 16 ELISA-negative with high background), 13 were found to be anti-Ago2/Su-positive in IP and ELISA. Only one IP-positive serum was judged to be ELISA-negative. Among the 13 patients with anti-Su/Ago2, 7 cases also had myositis-specific autoantibodies. Six sera that were positive by both IP and ELISA showed the GW body pattern in IIF. Interestingly, one ELISA-positive serum with an inconclusive result in IP also showed the GW body pattern. Conclusion: Our novel ELISA appears to be useful for screening anti-Su/Ago2 antibodies (sensitivity: 93%, specificity: 79%).
言語 en
出版者
出版者 Elsevier
言語 en
言語
言語 eng
資源タイプ
資源タイプresource http://purl.org/coar/resource_type/c_6501
タイプ journal article
出版タイプ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
DOI
関連タイプ isVersionOf
識別子タイプ DOI
関連識別子 https://doi.org/10.1016/j.cca.2017.06.022
ISSN
収録物識別子タイプ PISSN
収録物識別子 0009-8981
書誌情報 en : Clinica Chimica Acta

巻 471, p. 304-307, 発行日 2017-08
著者版フラグ
値 author
URI
識別子 http://doi.org/10.1016/j.cca.2017.06.022
識別子タイプ DOI
URI
識別子 http://hdl.handle.net/2237/27073
識別子タイプ HDL
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 13:51:46.143016
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3